Serina Therapeutics (SER) Intangibles (2017 - 2024)
Serina Therapeutics' (SER) quarterly Intangibles came in at $509000.0 in Q3 2024, down 61.2% year-over-year from $1.3 million in Q4 2023, and down 11.63% quarter-over-quarter from $576000.0 in Q2 2024.
Analysis
Serina Therapeutics (SER) Intangibles (2017 - 2024) Analysis & Trends
Serina Therapeutics has disclosed Intangibles across 8 years of filings, most recently posting $509000.0 for Q3 2024.
- In Q3 2024, Intangibles fell 61.2% year-over-year to $509000.0; the TTM figure through Sep 2024 stood at $509000.0 (down 61.2% YoY), while the FY2022 annual figure was $1.3 million, changed 0.0% from the prior year.
- Intangibles came in at $509000.0 for Q3 2024 at Serina Therapeutics, down from $576000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $2.0 million in Q1 2020 to a low of $509000.0 in Q3 2024.
- Average Intangibles over 5 years is $1.2 million, with a median of $1.3 million recorded in 2021.
- Year-over-year, Intangibles jumped 56.75% in 2023 and slumped 61.2% in 2024.
- Over 5 years, Intangibles stood at $1.6 million in 2020, then declined by 17.59% to $1.3 million in 2021, then changed by 0.0% to $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then tumbled by 61.2% to $509000.0 in 2024.
- Per Business Quant data, the three most recent Intangibles figures were $509000.0 in Q3 2024, $576000.0 in Q2 2024, and $576000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 20.49 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 14.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 412.80 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.31 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 266.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 13.52 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 576,000.00 |
| Mar 31, 2024 | 576,000.00 |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 837,000.00 |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 902,000.00 |
| Jun 30, 2021 | 935,000.00 |
| Mar 31, 2021 | 968,000.00 |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.73 Mn |
| Jun 30, 2020 | 1.87 Mn |
| Mar 31, 2020 | 2.01 Mn |
| Dec 31, 2019 | 2.15 Mn |
| Sep 30, 2019 | 2.29 Mn |